HIGHLIGHTS
- who: Masahiko Hatta from the Medical University of Tokyo, Minato-ku, Tokyo, Japan have published the Article: Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models, in the Journal: (JOURNAL) of 25/06/2022
- what: This study aimed to investigate the antitumor effect of T-01 which is a novel treatment for leiomyosarcoma. This study showed that oncolytic viral therapy provides an alternative treatment to chemotherapy for refractory sarcoma.
- how: Mouse experiments were conducted in accordance with the guide- Molecular Therapy Oncolytics Vol. In vitro data . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.